1.Otonomy Inc. (Nasdaq:OTIC) led advancing issues last week, rocketing 73% to $5.17. A Phase 3 clinical trial (AVERTS-2) assessing Otonomy’s Otividex in patients with Méni&egra… Read More

Tweet Thank You for your donations to cover server/software costs during 2017! I’m hoping to delay going to a subscription model as long as possible! Thank You. Stormchaser80, L.L.C.D… Read More

Welcome to this week’s Market Wrap Podcast, I’m Mike Gleason. Coming up Frank Holmes, CEO of U.S. Global Investors joins me to share his thoughts on Trump’s first 100 days… Read More

Market Review for KLCI:The FBM KLCI index lost 39.14 points or 2.31% on Monday. The Finance Index fell 1.82% to 13902.09 points, the Properties Index dropped 1.69% to 1167.5 points… Read More

My late grandfather, a man of sturdy Norwegian-American farm stock, who later became a newspaper editor and political activist during the First World War, used to say, 'A man can get use… Read More